Skip to main content

Table 6 Treatment of STEMI by ethnicity

From: Ethnic differences in the occurrence of acute coronary syndrome: results of the Malaysian National Cardiovascular Disease (NCVD) Database Registry (March 2006 - February 2010)

Treatment of STEMI

Ethnic Group

 

 χ2‡

df#

 p§

Malays

Chinese

Indians

Others*

No. (%)

No. (%)

No. (%)

No. (%)

Primary PCI

188 (5.6)

111 (9.0)

93 (7.9)

30 (7.4)

40.7

6

0.000

Fibrinolysis

2607 (78.1)

858 (69.5)

878 (74.3)

307 (76.2)

No reperfusion+

544 (16.3)

265 (21.5)

211 (17.9)

66 (16.4)

Total

3339 (100.0)

1234 (100.0)

1182 (100.0)

403 (100.0)

Fibrinolysis subgroup

       

Type of fibrinolytic drug used

       

Streptokinase

1924(97.1)

671(98.0)

661(96.2)

238(97.9)

4.3

3

0.226

Other fibrinolytic drugs

58(2.9)

14(2.0)

26(3.8)

5(2.1)

  

Door-to-needle time within 30 min

559(8.4)

181(5.9)

217(6.9)

54(7.5)

20.3

3

0.000

Door-to-needle time (min)†

50(27–100)

55(30–101)

49(24–102)

59(30–116)

10.7

3

0.013Â¥ (0.01, 0.02)Â¥

Door-to-balloon time (min)†

112(78–168)

109(73–156)

96(71–165)

81(48–124)

10.4

3

0.018Â¥ (0.01,0.02)Â¥

  1. *Others: Indigenous (Orang Asli), Kadazan, Melanau, Murut, Bajau, Bidayuh, Iban (minor ethnic groups) and other non-Malaysians.
  2. †Median (IQR).
  3. ‡Pearson Chi-Square.
  4. #Degree of freedom.
  5. §P value.
  6. +Reason for no reperfusion includes refusal, missed fibrinolysis, and contraindication.
  7. ¥Kruskal-Wallis test with Monte Carlo level of significance (99% CI).